Rapid, simple, inexpensive high-throughput antimicrobial susceptibility testing (AST) in natural product drug discovery and tackling antibiotic resistance in global infectious diseases.

Current evidence of increasing failure to antimicrobial therapy due to drug resistance may be leading us potentially into a post-antibiotic era, and thus threaten the advances made in medicine (Carlet et al., 2012). The worldwide surge in resistant bacteria and the paradoxical downward trend in the development of new antibiotics simultaneously have serious implications.

Dr (Mrs) Cynthia Amaning Danquah

BPharm (Hons), MPhil (Pharmacology), PhD (London), MPSGH